chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After second Moderna vaccine in March 2021 I became extremely I?ll and was checked on daily by CDC via text for approximately 3 months. Eventually all fine. Just got Pfizer booster yesterday 12-9-2021 started feeling I?ll around midnight. Now feeling quite sick. Lymph nodes enlarged and painful in both armpits and neck, overall a pan 8/10 for body, bone pain. Chills, possible fever, extreme fatigue, but can?t sleep due to entire body pain. Earache, headache/migraine. I haven?t checked for rash but had full body rash with Moderna. All joints very painful. Entire spine is the worst, along with joint pain.
Case previously recorded as MA2009-4182. Initial case report received from a physician via MedCom on 12 NOV 2009. A patient 3-year-old female was vaccinated with 0.5 mL S-OIV FLUVIRIN (batch no. 10073804) i.m on 11 NOV 2009. No adverse event was reported. MedCom reference no.: NA09-008134
Patient developed all over body itching about 1 hr. after vaccine. Patient took BENADRYL.
rashes on the face and even in few places on body as well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Lot number: FJ8757) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot number: EW0161), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE; Lot number: ER8736), for Covid-19 Immunization, reaction(s): "rashes on the face and even in few places on body as well". The following information was reported: RASH (non-serious), outcome "unknown", described as "rashes on the face and even in few places on body as well". The events "rashes on the face and even in few places on body as well" required physician office visit. Therapeutic measures were taken as a result of rash.  Additional information: Consumer stated, that he just wanted to check in case after taking the Pfizer vaccination for COVID, Are there any non-side effect with respected to any skin allergy on face. The patient is a software, Engineer. Consumer didn't have Expiration Date. The patient had three dosages of Vaccination. No lab test was done. The consumer had consulted dermatologist, who actually prescribed hydrocortisone to apply wherever the rashes on the face and even in few places on body as well. The patient did not receive other vaccines within four weeks prior to COVID vaccine. Anatomical site of vaccination consumer stated on arm left and right arm. Reporter stated, that after taking the vaccination only he was facing the problem of rashes and everything and rashes are not going away from last two years after he got vaccinated for the second dose.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200893189 same product and event, different dose;
Patient woke up the night after vaccination struggling to breath. We went to the ER, her oxygen saturation was 86% and her heart rate was 170, temp 101. It took nearly 12 hours for her to stabilize. We ended up back at the ER the following night. They ruled out RSV, flu, and covid. Her chest X-ray was clear. She never had an episode like this before and the doctors had no explanation. She still occasionally has difficulty breathing, esp if asked to wear a mask, which never happened before
The arm was red and hurt about 1 inch below the injection site.  The patient went to the ER and was diagnosed with cellulitis.
10 days after the vaccine I developed dizziness, tachycardia, dry mouth,chest pressure, shortness of breath and felt like I was going to pass out, and I had a feeling of extreme doom. I was transported to a clinic. There I had a heart rate of 140 with irregular beats. Continued feeling of doom. An EKG showed ST depression. Symptoms improved with nitroglycerin. The clinic didn't have the technology to provide care so I was emergently transported again. At that hospital my D-dimer was positive and that lead to a CT Angiogram. This showed a pulmonary embolism. Doppler studies of both legs were negative. I was placed on Heparin for several hours and then switched to Eliquis. About 6 hours after being on Eliquis I had the exact same original symptoms and again nitro was given which helped the symptoms. I was placed back on Heparin for a longer period of time. Once I was anticoagulated I was then switch to Eliquis 10mg BID for 7 days then 5mg BID for 6-9 months. I had a CT Angiogram of the head and neck which was normal. At this time I still have dizziness with standing and intermittently with sitting, extreme fatigue, shortness of breath.
Pt recvd vax on 6OCT92 & 5 hrs p/vax became nauseous & lightheaded w/voice fading; exp aching & chills during the noc; next day exp dizziness & stated that everything went black; throat & chest tightness & extremities began shaking; to ER;
The following day I woke up with bad body aches. then around 4 pm I started feeling nauseous and vomited intermittently for about 2 hours. I spent the rest of the day in bed. I was supposed to go to work the next day, but I had to call out, just not feeling up to it.  the next day I managed to go to work and was fine.
Information has been received from a licensed practical nurse concerning a 71 year old Caucasian female with allergies to MOTRIN and LEVAQUIN, who on 29-NOV-2007 was vaccinated IM in the right deltoid with the first dose of pneumococcal 23v polysaccharide vaccine (Lot# 659226/1419U). On 30-NOV-2007, the patient called the office to report that her right upper arm was very warm to the touch where the vaccine was given. There was no redness. The patient noticed it when rolling over in bed, and it woke her up. Treatment included cold compress and antihistamines (over the counter, not specified). At the time of the report, the outcome of the event was unknown. Additional information is not expected.
Patient reports nose began swelling and turning red early AM 10/30/2003.  Small earaser size blisters appeared, present at time of complaint.  Patient denies any recent contact with plants, new products, animals.  Denies any pain, itching,  or problems on site.  Reports slight tickle on nose at blister site.  Patient given HC creme as well as the doctor instructed to use benedryl creme if needed.
03:00AM contraction painfully cramps stomach and low back, nausea, felt like throwing up but couldn't chills r side of body pain -stabbing pain feeling, unable to lift arm overhead, felt like head swelling, severe headache; Goody's powder eased headache. 6AM -8PM fatigues, down feeling, loss of appetite, slight windedness, chills,  nausea ,headache, r side body in pain severe arm pain. Today only soreness in arm and some cramping in lower back
Wrong series was given to patient. Patient should have received Moderna bivalent and not Moderna monovalent.
Shortness of breath; Nausea; Vomiting; Fever of 102; A spontaneous report was received from a male consumer of unknown age, who was also the patient, who received Moderna's COVID-19 vaccine and experienced shortness of breath, nausea, vomiting, and fever of 102.   The patient's medical history was not provided. Concomitant medications were not provided by the reporter.   On 03 Jan 2021, approximately two days prior to the onset of symptoms, the patient received their first of two planned doses of mRNA-1273 (Lot number: Unknown) for prophylaxis of COVID-19 infection.   On 05 Jan 2021, the patient experienced nausea, vomiting, shortness of breath, and fever of 102. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was unknown.  The outcome for the events experienced shortness of breath, nausea, vomiting, and fever of 102 was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events two days after vacciination, a causal relationship cannot be excluded. Further information has been requested
I received my first Covid Shot on Oct 14th at 3:40 pm. A few minutes after the injection, my heart started to beat a lot faster and I experienced chest tightness. My breathing was a little bit heavier because of my chest tightness. I did not think much of it as I thought it would soon go away. I thought I was maybe just nervous. The symptoms slightly went away and I went back home without reporting any experienced symptoms.   Fast forward two months, to today, and my symptoms have worsened. Chest tightness has been constantly present over the past 24h. I can still breathe and function fine but I do have a constant chest tightness that weighs on me. I am unsure if I would benefit from any treatments.
had a bad reaction to the shots; hives all over; 1st dose on 16Jan2021 and 2nd dose on 23Feb2021; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (had a bad reaction to the shots) and URTICARIA (hives all over) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M207 and 011J20A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.    No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced IMMUNISATION REACTION (had a bad reaction to the shots) (seriousness criterion hospitalization), URTICARIA (hives all over) (seriousness criterion hospitalization) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 16Jan2021 and 2nd dose on 23Feb2021). The patient was hospitalized on 23-Feb-2021 due to IMMUNISATION REACTION and URTICARIA. At the time of the report, IMMUNISATION REACTION (had a bad reaction to the shots), URTICARIA (hives all over) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 16Jan2021 and 2nd dose on 23Feb2021) outcome was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter. No treatment medication was reported by reporter.  Patient received the Moderna vaccine primary series on 16 Jan 2021 and 23 Feb 2021. Patient reported it previously because patient had a bad reaction to the shots, hives all over was in the hospital and the doctor has taken her out of work. Safety follow-up consent with patient and HCP was given as yes. COMPANY COMMENT: This is an spontaneous case concerning a 68-years-old female patient with no medical history reported who experienced the unexpected seriousness criterion hospitalization  events of immunization reaction and urticaria the same day after  2nd.  dose of  mRNA-1273 vaccine.  Also, inappropriate schedule of product administration was noted in this case (more than 35 days between 1st. and 2nd. Doses). The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: COMPANY COMMENT: This is an spontaneous case concerning a 68-years-old female patient with no medical history reported who experienced the unexpected seriousness criterion hospitalization  events of immunization reaction and urticaria the same day after  2nd.  dose of  mRNA-1273 vaccine.  Also, inappropriate schedule of product administration was noted in this case (more than 35 days between 1st. and 2nd. Doses). The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
This case was reported by a other health professional via call center representative and described the occurrence of induration in a male patient who received BEXSERO (batch number 16B701A, expiry date 28th February 2019) for prophylaxis. On an unknown date, the patient received the 1st dose of BEXSERO. On an unknown date, less than a day after receiving BEXSERO, the patient experienced induration. On an unknown date, the outcome of the induration was recovered/resolved. It was unknown if the reporter considered the induration to be related to BEXSERO. Additional information received as follows: The age at vaccination was not reported. The patient experienced an induration of about 2 inches in diameter for approximately 2 weeks after vaccination with BEXSERO. The reporter did not give consent to follow-up. The healthcare professional not willing to provide the patient's details beyond gender.
This is a spontaneous report from a contactable consumer. A 65-year-old female patient received PREVNAR 13, via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she had a very bad reaction from the vaccination. Her arm was swollen, and she was just like in bed almost 2 weeks. She got the vaccination from pharmacy name. The patient also had fever, was throwing up, and had diarrhea on an unknown date. Outcome of all the events was unknown. Information on batch number has been requested.
chest tightness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the parent.  A 13 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 30Jul2021 18:30 (Lot number: FA6780) at the age of 13 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: CHEST DISCOMFORT (non-serious) with onset 15Aug2021, outcome "not recovered", described as "chest tightness".  Additional Information: Patient did not receive any other vaccine within 4 weeks of covid vaccine.  No follow-up attempts are possible. No further information is expected.
hives and "acute urticaria" all over her body; itchiness; lymph nodes were swollen; She could not lean her arm down at all, and could not leave it next to her body; The area under her armpit on the left side and on the side of her left breast turned black, blue, and humungous; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives and "acute urticaria" all over her body), PRURITUS (itchiness), HYPOKINESIA (She could not lean her arm down at all, and could not leave it next to her body), SKIN DISCOLOURATION (The area under her armpit on the left side and on the side of her left breast turned black, blue, and humungous) and VACCINATION SITE PAIN (arm pain) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013H21B, 037C21A and 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Dec-2021, the patient experienced HYPOKINESIA (She could not lean her arm down at all, and could not leave it next to her body) and SKIN DISCOLOURATION (The area under her armpit on the left side and on the side of her left breast turned black, blue, and humungous). 21-Dec-2021, the patient experienced VACCINATION SITE PAIN (arm pain). On 22-Dec-2021, the patient experienced LYMPHADENOPATHY (lymph nodes were swollen). On 01-Jan-2022, the patient experienced URTICARIA (hives and "acute urticaria" all over her body). 01-Jan-2022, the patient experienced PRURITUS (itchiness). The patient was treated with CORTISONE for Rash, at an unspecified dose and frequency. At the time of the report, URTICARIA (hives and "acute urticaria" all over her body), PRURITUS (itchiness), HYPOKINESIA (She could not lean her arm down at all, and could not leave it next to her body), SKIN DISCOLOURATION (The area under her armpit on the left side and on the side of her left breast turned black, blue, and humungous) and LYMPHADENOPATHY (lymph nodes were swollen) outcome was unknown and VACCINATION SITE PAIN (arm pain) had resolved.            No concomitant medications were reported. Itchiness got worse with scratching, and occur on her hands, feet, and scalp among other areas. Patient went to a dermatologist who advised her to use allergy medications. They also took blood work which appeared normal.
Pt presented to clinic for scheduled appointment to receive the Moderna booster shot. Pt well appearing NAD. Pt completed prescreen/immunization forms. All questions/concerns addressed. Pt tolerated vaccine shot well, no s/s rxn noted. After administration of this vaccine it was noted that this particular vial lot had expired 10/29/2021 and was not extended per Moderna list of extended lots. Moderna company contacted ASAP and their medical team will be in touch with our clinic to let us know what to do next in this situation. The patient has also been notified, no questions or concerns at this time- pt instructed to call clinic if any questions or concerns come up. Dr.  notified as well.
Fatigue, disorientation, fever, stiff neck, body aches, pain at injection site.
Cellulitis - confirmed by physician. Redness 4 inch x 3 inches, fever, soreness. Physician noted that it migrated to lymph nodes.
Initial information and follow up has been received from a physician's assistant and registered nurse concerning a white 16 year old female who on 13-DEC-2007 was vaccinated intramuscularly in the deltoid with her first dose of GARDASIL vaccine (yeast) (lot# 655154/1210U). There was no concomitant medication. On 03-JUN-2008 the mother informed the physician that the daughter experienced pain and swelling at the injection site on 13-DEC-2007. The patient was not seen as a result of this occurrence and has not decided not to continue the dosing series. Subsequently, the patient recovered from the pain and swelling at the injection site after 2 days. Additional information has been requested.
Hospital reported on 07/21/2003 that child received injury and had leg pain.  child had been given Tylenol and Motrin and warm bath.
A report has been received from a Health Professional concerning a 7 year old, Male subject, who had been receiving FLUMIST quadrivalent (intranasal). The patient's concurrent disease(s) included asthma. Concomitant medications included fluticasone propionate and salbutamol. FLUMIST quadrivalent (intranasal) started on 25-Sep-2013. It was reported that FLUMIST quadrivalent was given unintentionally to a patient with asthma. Patient was not reporting any symptoms. FLUMIST quadrivalent (intranasal) was discontinued on 25-Sep-2013. The outcome of the event of given unintentionally to a patient with asthma is unknown. The report was considered to be non-serious.
pt recieved 0.2 ml of undiluted vaccine for pfizer covid (5-11) as first dose
itching; shingles reaction; This case was reported by a consumer via interactive digital media and described the occurrence of pruritus in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included fluticasone furoate, umeclidinium bromide, vilanterol trifenatate (Trelegy Ellipta).   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix and an unknown time after starting Trelegy Ellipta, the patient experienced pruritus and adverse reaction. On an unknown date, the outcome of the pruritus and adverse reaction were unknown.   It was unknown if the reporter considered the pruritus and adverse reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per the vaccine indication. After receiving Shingrix, the patient experianced itching and shingles vaccine reaction. The patient was asking that what home remedy could the patient use for the itching and shingles vaccine reaction.
Patient describes injection site as constantly itching. Was swollen at first but site continues to itch from admin date to today, 11/25/16.
My skin and muscles began to feel numb and almost chilled for about 36 hours.  I also felt light headed and foggy.
12 hours after it woke me up, stomach hurting, chills, tired, diarrhea, this went on and off during the day but lasted seven days
pt recvd vax & had rash on forearm; pt still had rash 1 mo later;
Information has been received from a registered nurse and a health care professional concerning a 5 year old white female with a history of "allergy-induced ear infections" and no known allergies who on the morning of 08/15/2002 was vaccinated subcutaneously in the left arm with a second dose of measles vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(Lot # 642181/0183M)(also reported as Lot 0183U-invalid).  Concomitant vaccination on 08/15/2002 included a fifth dose of aluminum, potassium (+) diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid (Tripedia)(Lot # C0725AA) intramuscularly in the right arm and a fourth dose of poliovirus vaccine (IPOL)(Lot # U1234) subcutaneously in the right arm.  There was no illness at teh time of vaccination and the patient was not currently taking any medications.  On the evening of 08/16/2002, the patient developed an injection site reaction and at 22:04, the patient presented to the emergency room with a 12cm x 8cm indurated, erythematous, warm lesion over her right deltoid.  The area was nontender, had no adenopathy, no streaking, and no shoulder or elbow involvement.  The patient did not have diarrhea, fever, cough, vomiting, adenopathy, constitutional symptoms, jaundice, nausea, chills or dizziness.  The patient had a normal appetite and normal urine output.  The patient's vital signs were reported as temperature 37.3C, pulse 103, respirations 28, and blood pressure 94/69.  The patient was diagnosed with a local reaction to the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) in the right deltoid (reported as administered in the left arm).  At 12:20 am the patient was discharged from the emergency room and ibuprofen (Motrin) and warm compresses were suggested.  The patient was to follow-up with physician in the morning.  On 08/22/2002, the patient recovered.  On 10/29/2002, the administering nurse reported that she has "a systematic way of administering vaccinations" because she gives so many of them.  The reporter stated that she has a list of required immunizations are due, always starting with the left arm.  The reporter stated that she knows that she would have started with the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) in the left arm.  The reporter also stated that she had noticed the discrepancy in the ER report, reporting that the reaction was in the right arm and therefore would have been the site of the aluminum, potassium (+) diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid and poliovirus vaccine and not the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  However, the reporter stated that she does not know if the patient's mother reported to the ER physician that the right arm was the site of the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation), and that possibly the mother misunderstood the sites of vaccination.  Additional information is not expected.
Pfizer 3/31/21, 4/13/21, 12/3/21, 8/18/22. Positive on 11/26/22